(ATR) AptarGroup - Ratings and Ratios
Pumps, Valves, Closures, Elastomeric Components, Aerosol Valves
ATR EPS (Earnings per Share)
ATR Revenue
Description: ATR AptarGroup
AptarGroup Inc (NYSE:ATR) is a leading global provider of innovative drug delivery, dispensing, and active material science solutions across various industries, including pharmaceutical, beauty, personal care, home care, and food and beverage. The companys diversified product portfolio includes pumps, valves, elastomeric components, and digital health solutions.
With operations segmented into Aptar Pharma, Aptar Beauty, and Aptar Closures, the company has a strong presence in Asia, Europe, Latin America, and North America, catering to a broad customer base. AptarGroups solutions are designed to enhance the delivery and dispensing of various products, including nasal allergy treatments, respiratory medications, and injectable packaging components.
To evaluate AptarGroups performance, key performance indicators (KPIs) such as Revenue Growth, Operating Margin, and Return on Equity (RoE) are crucial. With a RoE of 14.87%, the company demonstrates a strong ability to generate profits from shareholder equity. Additionally, the companys dividend yield and payout ratio can be analyzed to assess its commitment to returning value to shareholders.
Further analysis of AptarGroups financials reveals that its Market Cap stands at $10.3 billion, indicating a significant market presence. The companys Price-to-Earnings (P/E) ratio of 28.59 suggests that investors are willing to pay a premium for its shares, potentially due to its strong growth prospects and industry leadership.
To gain a deeper understanding of AptarGroups competitive position, metrics such as market share, customer concentration, and product innovation pipeline can be examined. The companys ability to expand its product offerings and penetrate new markets will be crucial in driving future growth and maintaining its competitive edge.
ATR Stock Overview
| Market Cap in USD | 9,301m |
| Sub-Industry | Metal, Glass & Plastic Containers |
| IPO / Inception | 1993-04-21 |
ATR Stock Ratings
| Growth Rating | 4.45% |
| Fundamental | 74.3% |
| Dividend Rating | 53.8% |
| Return 12m vs S&P 500 | -19.2% |
| Analyst Rating | 4.29 of 5 |
ATR Dividends
| Dividend Yield 12m | 1.23% |
| Yield on Cost 5y | 1.62% |
| Annual Growth 5y | 3.62% |
| Payout Consistency | 100.0% |
| Payout Ratio | 30.7% |
ATR Growth Ratios
| Growth Correlation 3m | -41.7% |
| Growth Correlation 12m | -39.7% |
| Growth Correlation 5y | 56.1% |
| CAGR 5y | 4.73% |
| CAGR/Max DD 5y | 0.12 |
| Sharpe Ratio 12m | 0.92 |
| Alpha | -16.45 |
| Beta | 0.515 |
| Volatility | 33.58% |
| Current Volume | 442.9k |
| Average Volume 20d | 519.2k |
| Stop Loss | 135.5 (-3%) |
| Signal | 0.61 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (391.5m TTM) > 0 and > 6% of Revenue (6% = 216.6m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.15% (prev 11.96%; Δ -3.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 698.9m > Net Income 391.5m (YES >=105%, WARN >=100%) |
| Net Debt (974.5m) to EBITDA (808.8m) ratio: 1.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.3m) change vs 12m ago -0.46% (target <= -2.0% for YES) |
| Gross Margin 36.38% (prev 36.94%; Δ -0.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 77.49% (prev 79.87%; Δ -2.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.75 (EBITDA TTM 808.8m / Interest Expense TTM 45.9m) >= 6 (WARN >= 3) |
Altman Z'' 3.97
| (A) 0.06 = (Total Current Assets 1.66b - Total Current Liabilities 1.37b) / Total Assets 4.87b |
| (B) 0.51 = Retained Earnings (Balance) 2.50b / Total Assets 4.87b |
| (C) 0.12 = EBIT TTM 538.8m / Avg Total Assets 4.66b |
| (D) 1.07 = Book Value of Equity 2.30b / Total Liabilities 2.15b |
| Total Rating: 3.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.32
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 3.34% = 1.67 |
| 3. FCF Margin 9.46% = 2.37 |
| 4. Debt/Equity 0.40 = 2.42 |
| 5. Debt/Ebitda 1.34 = 1.23 |
| 6. ROIC - WACC 4.72% = 5.90 |
| 7. RoE 15.28% = 1.27 |
| 8. Rev. Trend 64.78% = 3.24 |
| 9. Rev. CAGR 5.36% = 0.67 |
| 10. EPS Trend 81.92% = 2.05 |
| 11. EPS CAGR 29.57% = 2.50 |
What is the price of ATR shares?
Over the past week, the price has changed by +0.09%, over one month by -11.97%, over three months by -11.42% and over the past year by -5.90%.
Is AptarGroup a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ATR is around 121.68 USD . This means that ATR is currently overvalued and has a potential downside of -12.91%.
Is ATR a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ATR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 171.5 | 22.8% |
| Analysts Target Price | 175 | 25.3% |
| ValueRay Target Price | 134.1 | -4.1% |
Last update: 2025-08-21 11:10
ATR Fundamental Data Overview
CCE Cash And Equivalents = 161.7m USD (last quarter)
P/E Trailing = 24.3834
P/E Forward = 25.8398
P/S = 2.576
P/B = 3.4447
P/EG = 4.3746
Beta = 0.574
Revenue TTM = 3.61b USD
EBIT TTM = 538.8m USD
EBITDA TTM = 808.8m USD
Long Term Debt = 535.1m USD (from longTermDebt, last quarter)
Short Term Debt = 551.5m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (Calculated: Short Term 551.5m + Long Term 535.1m)
Net Debt = 974.5m USD (from netDebt column, last quarter)
Enterprise Value = 10.23b USD (9.30b + Debt 1.09b - CCE 161.7m)
Interest Coverage Ratio = 11.75 (Ebit TTM 538.8m / Interest Expense TTM 45.9m)
FCF Yield = 3.34% (FCF TTM 341.6m / Enterprise Value 10.23b)
FCF Margin = 9.46% (FCF TTM 341.6m / Revenue TTM 3.61b)
Net Margin = 10.84% (Net Income TTM 391.5m / Revenue TTM 3.61b)
Gross Margin = 36.38% ((Revenue TTM 3.61b - Cost of Revenue TTM 2.30b) / Revenue TTM)
Tobins Q-Ratio = 4.45 (Enterprise Value 10.23b / Book Value Of Equity 2.30b)
Interest Expense / Debt = 1.00% (Interest Expense 10.8m / Debt 1.09b)
Taxrate = 20.35% (from yearly Income Tax Expense: 95.6m / 469.8m)
NOPAT = 429.2m (EBIT 538.8m * (1 - 20.35%))
Current Ratio = 1.21 (Total Current Assets 1.66b / Total Current Liabilities 1.37b)
Debt / Equity = 0.40 (Debt 1.09b / last Quarter total Stockholder Equity 2.70b)
Debt / EBITDA = 1.34 (Net Debt 974.5m / EBITDA 808.8m)
Debt / FCF = 3.18 (Debt 1.09b / FCF TTM 341.6m)
Total Stockholder Equity = 2.56b (last 4 quarters mean)
RoA = 8.05% (Net Income 391.5m, Total Assets 4.87b )
RoE = 15.28% (Net Income TTM 391.5m / Total Stockholder Equity 2.56b)
RoCE = 17.40% (Ebit 538.8m / (Equity 2.56b + L.T.Debt 535.1m))
RoIC = 11.88% (NOPAT 429.2m / Invested Capital 3.61b)
WACC = 7.17% (E(9.30b)/V(10.39b) * Re(7.91%)) + (D(1.09b)/V(10.39b) * Rd(1.00%) * (1-Tc(0.20)))
Shares Correlation 5-Years: 20.0 | Cagr: -0.06%
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈334.1m ; Y1≈412.2m ; Y5≈703.3m
Fair Price DCF = 181.6 (DCF Value 11.96b / Shares Outstanding 65.9m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 64.78 | Revenue CAGR: 5.36%
Rev Growth-of-Growth: -2.88
EPS Correlation: 81.92 | EPS CAGR: 29.57%
EPS Growth-of-Growth: -8.17
Additional Sources for ATR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle